|Rapid Review Complete
|Loxapine inhalation powder
|For the rapid control of mild-to-moderate agitation in adult patients with schizophrenia or bipolar disorder.
|Rapid review commissioned
|Rapid review completed
|Rapid review outcome
|Full Pharmacoeconomic Assessment Recommended.
Not considered cost-effective due to non-submission of full pharmacoeonomic evaluation.